
Joe Betts-LaCroix
American scientist and entrepreneur
2
APPEARANCES
2
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
Jun 20, 2026
Joe Betts-LaCroix: Inside Retro Biosciences — Reprogramming, Autophagy & the Race to Clinical Trials | Frameshifts Episode #13
42:03
42:21
42:35
42:52
42:57
74:08

Benjamin AryaHOST
And for our audience's sake, how does targeting work when you have organ-specific, tissue-specific, and cell type-specific targeting of these reprogramming factors? What's the actual method of delivery that's

Joe Betts-LaCroixGUEST
One is very crude, but you can target by choosing where you inject something that causes those transcription factors to be expressed.

Joe Betts-LaCroixGUEST
For instance, if you inject it in the eye, which I know sounds grisly, but there are these tiny little needles and lots and lots of eye injections happen these days.

Joe Betts-LaCroixGUEST
For the most part, it doesn't end up going all over the place and into the rest of the body.

Joe Betts-LaCroixGUEST
The second would be to use vectors that only go into certain types of cells.
31 MINS LATER

Benjamin AryaHOST
A lot of big generational tech companies leave this legacy of not just like the products and services that they created, but also the mafia of individuals that sort of leave that company and start their own companies and have their own significant impact and generate value for economy and for humanity, what would you hope the team at Retro will get up to after you've achieved these goals?
Longevity Scientist: Aging Is A Disease. We Just Don’t Know How to Treat (yet)
10:16
10:23
35:06

Joe Betts-LaCroixGUEST
And then we learn more and then we can tweak our model and make a new intervention and try again.

Joe Betts-LaCroixGUEST
And it's all got, as the backdrop against it, our imperfect knowledge of biology.
25 MINS LATER

Julian IssaHOST
I think we still haven't grasped what is happening right now and what people like yourself and Sam are doing.